Details of the Drug

General Information of Drug (ID: DMXDPGC)

Drug Name
AGB101
Indication
Disease Entry ICD 11 Status REF
Cognitive impairment 6D71 Phase 2 [1]
Cross-matching ID
TTD ID
D0A2XY

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)